We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.02B
1-Year Est. Return 53.92%
This Fund
S&P 500
This Quarter Est. Return
+5.72%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$3.14B
AUM Growth
-$171M
Cap. Flow
-$231M
Cap. Flow %
-7.38%
Top 10 Hldgs %
16.05%
Holding
444
New
72
Increased
89
Reduced
94
Closed
73

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$29.5M
2
MIDD icon
Middleby
MIDD
+$25.9M
3
PH icon
Parker-Hannifin
PH
+$25.1M
4
VEEV icon
Veeva Systems
VEEV
+$23M
5
DKS icon
Dick's Sporting Goods
DKS
+$22.8M

Sector Composition

Rank Sector Weight
1 Technology 18.38%
2 Energy 14.09%
3 Industrials 13.84%
4 Healthcare 13.22%
5 Consumer Discretionary 11.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HD icon
1
Home Depot
HD
$339B
$58.6M 1.87%
436,691
-49,049
-10% -$6.32M
MSFT icon
2
Microsoft
MSFT
$2.9T
$56.9M 1.81%
915,124
+295,674
+48% +$17.8M
EOG icon
3
EOG Resources
EOG
$76.9B
$54.3M 1.73%
537,489
-93,551
-15% -$9.11M
UNH icon
4
UnitedHealth
UNH
$391B
$52M 1.66%
325,120
+25,090
+8% +$3.75M
EEM icon
5
iShares MSCI Emerging Markets ETF
EEM
$27.8B
$49.9M 1.59%
1,425,000
GE icon
6
GE Aerospace
GE
$373B
$48.3M 1.54%
318,648
-35,973
-10% -$5.23M
SCHW
7
Charles Schwab
SCHW
$185B
$48.1M 1.53%
1,219,123
+610,973
+100% +$21.8M
ABMD
8
DELISTED
Abiomed Inc
ABMD
$45.9M 1.46%
407,439
+45,012
+12% +$5.21M
ADBE icon
9
Adobe
ADBE
$99.2B
$45.5M 1.45%
442,398
-79,902
-15% -$8.46M
MCHP icon
10
Microchip Technology
MCHP
$40.9B
$43.7M 1.4%
1,363,706
+319,466
+31% +$10M
MDT icon
11
Medtronic
MDT
$111B
$41.6M 1.33%
583,746
+64,076
+12% +$5.03M
AMAT icon
12
Applied Materials
AMAT
$371B
$41.3M 1.32%
1,280,553
+75,053
+6% +$2.28M
GOOG icon
13
Alphabet (Google) Class C
GOOG
$4.09T
$40.3M 1.28%
1,043,620
-353,480
-25% -$13.8M
DVN icon
14
Devon Energy
DVN
$50.7B
$40.3M 1.28%
881,814
-200,326
-19% -$8.85M
PANW icon
15
Palo Alto Networks
PANW
$259B
$37.4M 1.19%
1,793,088
+374,868
+26% +$8.98M
CME icon
16
CME Group
CME
$94.1B
$33.4M 1.07%
289,723
-192,477
-40% -$21.4M
ULTA icon
17
Ulta Beauty
ULTA
$21.4B
$33.4M 1.07%
131,046
-89,249
-41% -$22.3M
MS icon
18
Morgan Stanley
MS
$333B
$32.9M 1.05%
+779,714
New +$29.5M
TPR icon
19
Tapestry
TPR
$30B
$32.5M 1.04%
927,225
-175,870
-16% -$6.42M
APTV icon
20
Aptiv
APTV
$12.6B
$32.3M 1.03%
479,212
+30,992
+7% +$2.08M
MIDD icon
21
Middleby
MIDD
$6.01B
$31.5M 1.01%
244,620
+205,875
+531% +$25.9M
EW icon
22
Edwards Lifesciences
EW
$48B
$30.5M 0.97%
976,149
-611,841
-39% -$19.8M
CLR
23
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$29.6M 0.95%
575,168
+17,628
+3% +$912K
BIIB icon
24
Biogen
BIIB
$31.2B
$29.6M 0.94%
104,396
-11,984
-10% -$3.55M
AMZN icon
25
Amazon
AMZN
$2.47T
$28.6M 0.91%
763,200
-573,400
-43% -$22.5M

Similar funds

Castleark Management's Q4 2016 Portfolio in Review

As of Q4 2016, Castleark Management held 444 positions worth $3.14B, down 5.2% from $3.31B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Castleark Management withdrew a net $231M in Q4 2016, closing 73 positions and reducing 94 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Energy and Industrials.

Against the trend, Castleark Management opened a new position in Morgan Stanley worth $32.9M.

  • Castleark Management's largest Q4 2016 buy was Morgan Stanley: 779,714 shares worth $32.9M.
  • Castleark Management added most to Middleby in Q4 2016, an estimated $25.9M increase.
  • Castleark Management's biggest Q4 2016 reduction was NXP Semiconductors, cutting an estimated $43.4M.
  • Castleark Management fully exited Bristol-Myers Squibb in Q4 2016, selling an estimated $22.8M.
  • Castleark Management's ten largest holdings make up 16% of its $3.14B portfolio in Q4 2016.
  • Castleark Management opened 72 new positions and closed 73 in Q4 2016.
  • Castleark Management's portfolio value fell 5.2% quarter-over-quarter to $3.14B.

Based on Castleark Management's 13F filing for Q4 2016, filed 15 Feb 2017.